Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181

NCT01446770 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Halscion, Inc.